Skip to content
Screener

Lipocine LPCN Q2 2025 earnings

Reported August 5, 2025 · Before market open

Revenue$622.8KBeat by $384.8K
EPS-$0.41In line
Revenue estimate$238.0K
EPS estimate-$0.41

Next report

Nov 5, 2026 (in a month)
Revenue estimate$159.5K
EPS estimate-$0.39

FAQ

When did Lipocine report Q2 2025 earnings?
Lipocine (LPCN) reported Q2 2025 earnings on August 5, 2025 before market open.
What were Lipocine's Q2 2025 revenue and EPS?
Lipocine reported revenue of $622.8K and eps of $-0.41 for Q2 2025.
Did Lipocine beat estimates in Q2 2025?
Revenue beat the consensus estimate of $238.0K by $384.8K. EPS beat the consensus estimate of $-0.41 by $0.00.
How did Lipocine's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 595.4% from $89.6K a year earlier and eps grew 26.8% from $-0.56.
Where can I find Lipocine's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-011589) and the 10-Q periodic report (0001493152-25-011588) directly on SEC EDGAR. The filing index links above go to sec.gov.